Inovio Pharmaceuticals, Inc. Financial Ratios — INO Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-32.52	-48.17	-152.12	-44.14	-20.35	-49.33	-66.4	-84.57	-264.15	-71.64	-70.55	-89.97	-79.55	-115.42	-183.47
Return on Assets (%)	-26.03	-37.03	-98.97	-32.83	-16.89	-38.05	-48.87	-60.92	-86.79	-48.68	-58.64	-66.27	-52.02	-75.49	-90.61
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100
EBITDA Margin (%)	-206.36	-549.93	-144.39	-362.7	-82.24	-209.65	-192.26	-292.29	-2,567.95	-1,611.8	-16,705.78	-2,553.8	-15,615.57	-50,179.5	-128,297.25
Operating Margin (%)	-226.9	-598.36	-159.97	-377.71	-86.97	-218.38	-200.48	-308.68	-2,702.1	-1,674.25	-16,972.34	-2,607.35	-16,036.67	-51,616.91	-132,871.32
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-156.24	-478.63	-490.69	-345.61	-76.9	-208.49	-208.92	-311	-2,938.01	-2,197.89	-17,085.39	-2,705.57	-16,239.87	-49,254.27	-130,000
Profit Margin (%)	-155.72	-477.56	-490.29	-345.44	-71.94	-208.49	-208.92	-318.12	-2,902.75	-2,245.39	-17,109.87	-2,726.67	-16,239.87	-49,254.27	-130,000
Net Income to Common Margin (%)	-155.72	-477.56	-490.29	-345.44	-71.94	-208.49	-208.92	-318.12	-2,902.75	-2,245.39	-17,109.87	-2,726.67	-16,239.87	-49,254.27	-130,000
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-32.52	-48.17	-152.12	-44.14	-20.35	-49.33	-66.4	-84.57	-264.15	-71.64	-70.55	-89.97	-79.55	-115.42	-183.47

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	100	39	33	32	30	12	9
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	2	2	3	3	19	2	3
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	97	37	30	29	11	9	7
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	-0.94	-0.33	-0.11	-0.12	-0.23	-0.11	-0.11
Net Debt/EBITDA	0.86	0.25	1.73	1.07	1.73	0.26	0.29	0.27	-0.52	1.94	0.19	0.11	-0.02	0.6	0.53
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	-0.9	-0.31	-0.11	-0.12	-0.23	-0.11	-0.11
Net Debt/EBIT	0.78	0.23	1.57	1.03	1.63	0.25	0.28	0.25	-0.49	1.87	0.19	0.11	-0.02	0.59	0.51
EBITDA to Interest Expense	-589.58	- -	- -	- -	- -	- -	-3,130.14	- -	-13.28	-13.73	-153.11	-209	-106.25	-614.45	- -
EBITDA-CapEx/Interest Expense	-594.28	- -	- -	- -	- -	- -	-3,527.08	- -	-13.41	-13.9	-153.74	-209.77	-106.51	-617.19	- -
EBIT to Interest Expense	-648.26	- -	- -	- -	- -	- -	-3,263.91	- -	-13.98	-14.26	-155.55	-213.38	-109.12	-632.05	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	8	9	2	1	1	- -	- -
Common Equity/Total Assets	77.43	76.11	59.41	84.4	82.16	70.97	76.05	66.31	2.39	85.43	80.59	63.8	68.64	60.52	32.43
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	1,802.69	7.96	7.61	13.16	9.4	13.67	27.16
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	92.87	7.34	7.03	11.5	7.48	11.66	19.56
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	67.68	6.8	6.13	8.4	6.45	8.28	8.81
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	1,841.08	8.47	8.26	14.42	25.74	17.32	38.88
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	94.85	7.81	7.63	12.61	20.47	14.76	27.99
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	69.13	7.23	6.66	9.2	17.67	10.48	12.61
Net Debt to Equity	-36.25	-16.2	-63.74	-36.35	-32.76	-15.51	-16.69	-27.22	1,014.4	-50.33	-14.06	-13.36	2.1	-96.07	-183.74
Net Debt/Capital (%)	-56.86	-19.33	-175.78	-57.11	-48.72	-18.36	-20.04	-37.41	66.28	-93.03	-15.54	-14.28	1.85	-452.15	409.59
EBITDA	-20	-23	-19	-38	-33	-74	-81	-89	-106	-119	-296	-262	-130	-109	-84
EBITDA-CapEx	-20	-23	-20	-39	-36	-78	-91	-91	-107	-121	-298	-263	-130	-110	-84
Operating Income (Loss)	-22	-25	-22	-39	-35	-77	-85	-94	-111	-124	-301	-268	-133	-112	-87

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	2.74	1.63	1.82	6.65	5.18	2.39	3.6	2.3	2.8	9.87	6.1	2.61	3.41	2.66	1.34
Current Ratio	2.89	1.91	2.03	7.02	5.46	2.84	3.91	2.49	2.94	11.3	6.82	3.25	3.6	2.77	1.4
Quick Ratio	2.78	1.74	1.93	6.85	5.41	2.77	3.78	2.42	2.86	10.33	6.23	2.73	3.47	2.7	1.34
CFO/Avg Current Liab	-2.26	-2.3	-0.82	-1.39	-0.55	-1.66	-1.6	-2.08	-2.91	-4.83	-4.02	-2.66	-1.78	-2.67	-2.24
Common Equity/Total Assets	77.43	76.11	59.41	84.4	82.16	70.97	76.05	66.31	2.39	85.43	80.59	63.8	68.64	60.52	32.43
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	1,802.69	7.96	7.61	13.16	9.4	13.67	27.16
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	92.87	7.34	7.03	11.5	7.48	11.66	19.56
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	67.68	6.8	6.13	8.4	6.45	8.28	8.81
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	1,841.08	8.47	8.26	14.42	25.74	17.32	38.88
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	94.85	7.81	7.63	12.61	20.47	14.76	27.99
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	69.13	7.23	6.66	9.2	17.67	10.48	12.61
CFO/Total Liabilities	-149.16	-216.96	-43.47	-147.3	-32.81	-124.29	-141.25	-166.85	-70.63	-226.35	-224.06	-171.37	-232.02	-232.87	-176.5
CFO/CapEx	-122.56	-92.56	-86.94	-21.61	-4.47	-15.88	-6.14	-35.28	-99.05	-117.04	-175.23	-223.1	-387.55	-213.35	-310.22
Altman's Z-Score	-5.35	-9.94	4.32	12.39	5.61	1.43	0.05	-4.08	-8.75	10.42	2.15	-6.14	-13.52	-23.12	-36.34

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	32.04	6	6.46	3.43	8	2.96	3.66	5.78	1.35	0.7	0.13	1.04	0.12	0.12	0.11
Days Sales Outstanding	11.39	60.84	56.48	106.56	45.6	123.34	99.68	63.13	270.16	519.48	2,786.29	351.59	3,102.34	3,020.73	3,350.17
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	58	72	610	558	485	514	373	389	334	1,654	1,085	395	139	66	120
- Cash & Cash Equivalents	17	6	34	41	58	19	24	24	22	251	71	46	14	66	44
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	1	1	- -	- -	- -	- -	- -	- -	2	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	100	39	33	32	30	12	9
Enterprise Value	28	59	558	464	323	409	246	308	346	1,281	716	174	24	-16	71
Total Capital	48	35	53	112	176	123	142	87	105	500	433	254	148	80	33
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	94.85	7.81	7.63	12.61	20.47	14.76	27.99
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	0.29	0.03	0.05	0.18	1.24	-0.73	0.13
EV/Sales	2.9	14.32	41.41	44.4	7.95	11.57	5.82	10.1	84.25	172.85	403.69	16.95	29.34	- -	1,085.19
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	54	68	535	545	459	508	338	370	326	1,373	1,042	372	136	50	82
Diluted Enterprise Value	37	63	501	505	402	489	315	347	405	1,161	1,004	358	152	-4	47
EV per Share	10.09	19.62	127.29	91.73	53.6	66.32	32.65	37.99	41.01	82.27	39.55	8.25	1.07	- -	1.03
TTM Sales	10	4	13	10	41	35	42	30	4	7	2	10	1	- -	- -
TTM EBITDA	-20	-23	-19	-38	-33	-74	-81	-89	-106	-119	-296	-262	-130	-109	-84
TTM Operating Income	-22	-25	-22	-39	-35	-77	-85	-94	-111	-124	-301	-268	-133	-112	-87
TTM Cash Flow to Firm	-20	-22	-15	-30	-12	-63	-63	-74	-90	-169	-214	-215	-123	-104	-89
TTM Free Cash Flow to Firm	-20	-22	-15	-28	-10	-59	-53	-71	-89	-168	-213	-214	-123	-103	-88

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-2.77	-3.09	-35.16	-19.17	-47.57	-8.67	-6.39	-5.18	-3.36	-7.78	-4.86	-1.73	-1.09	-0.48	-0.92
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	28	59	558	464	323	409	246	308	346	1,281	716	174	24	-16	71
Low Price	16.8	18.24	23.52	89.76	63.84	54	49.08	43.68	23.04	35.4	59.88	16.56	3.84	1.74	1.3
EV/Sales	2.9	14.32	41.41	44.4	7.95	11.57	5.82	10.1	84.25	172.85	403.69	16.95	29.34	- -	1,085.19
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-6.8	-3.82	-3.59	-17.31	-18.01	-8.29	-5.82	-4.49	-2.58	-10.99	-5.83	-2.15	-1.45	-2.01	-1.11
Price/Earnings High	-12.91	-6.25	-8.46	-25.86	-25.3	-11.61	-9.14	-6.01	-4.23	-31.5	-13.07	-4.49	-3.92	-3.74	-1.64
Price/Earnings Low	-2.9	-2.64	-1.37	-12.24	-12.43	-4.47	-3.79	-3.47	-1.59	-2.75	-3.43	-1.18	-0.63	-0.44	-0.72
Price/Book Value	1.23	2.1	11.63	5.01	2.76	4.17	2.62	4.47	97.37	3.59	2.71	1.78	1.19	0.96	4.98
Price/Book Value Average	2.34	2.31	5.16	5.78	3.17	5.02	3.99	5.26	92.2	4.78	4.61	2.87	1.72	4.18	5.76
Price/Book Value High	4.45	3.78	12.15	8.63	4.45	7.02	6.26	7.05	150.78	13.69	10.33	6	4.64	7.77	8.53
Price/Book Value Low	1	1.6	1.96	4.08	2.19	2.7	2.6	4.07	56.65	1.2	2.71	1.57	0.75	0.92	3.72
Price/Tangible Book Value	2.08	4.31	16.65	5.79	3	4.89	2.96	5.43	-31.05	3.7	2.81	1.88	1.19	0.96	4.98
Price/Tangible Book Value Average	3.97	4.75	7.39	6.67	3.44	5.88	4.51	6.38	-29.4	4.92	4.77	3.05	1.72	4.18	5.76
Price/Tangible Book Value High	7.55	7.75	17.4	9.96	4.84	8.23	7.08	8.55	-48.08	14.11	10.69	6.36	4.64	7.77	8.53
Price/Tangible Book Value Low	1.69	3.27	2.81	4.72	2.38	3.17	2.94	4.94	-18.07	1.23	2.81	1.67	0.75	0.92	3.72
Price/Sales	5.54	16.57	39.7	51.91	11.3	14.37	8	12.14	79.23	185.24	587.16	36.27	163.1	228.26	1,248.52
Price/Sales Average	10.58	18.26	17.62	59.81	12.96	17.29	12.17	14.28	75.02	246.85	997.02	58.72	236.19	990.23	1,442.92
Price/Sales High	20.1	29.83	41.48	89.34	18.2	24.2	19.1	19.13	122.68	707.27	2,235.67	122.54	636.42	1,839.78	2,138.28
Price/Sales Low	4.51	12.59	6.71	42.3	8.94	9.32	7.92	11.05	46.09	61.75	587.16	32.09	102.34	217.03	932.81
Price/Cash Flow	-2.75	-3.06	-34.76	-18.2	-36.84	-8.12	-5.34	-5.03	-3.33	-7.71	-4.83	-1.72	-1.09	-0.48	-0.92
Price/Cash Flow Average	-5.25	-3.37	-15.42	-20.97	-42.27	-9.77	-8.13	-5.92	-3.15	-10.28	-8.2	-2.79	-1.58	-2.07	-1.06
Price/Cash Flow High	-9.97	-5.51	-36.32	-31.32	-59.38	-13.68	-12.76	-7.93	-5.16	-29.45	-18.39	-5.82	-4.26	-3.85	-1.58
Price/Cash Flow Low	-2.24	-2.33	-5.87	-14.83	-29.17	-5.27	-5.29	-4.58	-1.94	-2.57	-4.83	-1.52	-0.68	-0.45	-0.69
Price/Free Cash Flow Average	-5.29	-3.41	-15.6	-22.09	-54.57	-10.43	-9.72	-6.09	-3.18	-10.37	-8.25	-2.8	-1.58	-2.08	-1.07
Price/Free Cash Flow High	-10.05	-5.57	-36.74	-33	-76.67	-14.6	-15.26	-8.16	-5.21	-29.71	-18.5	-5.84	-4.27	-3.87	-1.58
Price/Free Cash Flow Low	-2.25	-2.35	-5.94	-15.62	-37.66	-5.62	-6.33	-4.71	-1.96	-2.59	-4.86	-1.53	-0.69	-0.46	-0.69
EV/Sales Average	9.6	18.05	17.63	57.59	12.31	16.95	12.88	14.23	96.31	268.77	1,016.38	60.89	261.89	1,068.38	1,589.17
EV/Sales High	19.78	30.29	44.85	87.93	17.86	23.94	20.54	19.32	145.24	823.35	2,305.75	128.58	673.31	2,197.54	2,612.44
EV/Sales Low	3.11	12.07	5.18	39.6	8.06	8.88	8.19	10.84	66.61	45.81	589.73	32.64	124.31	40.71	838.5
EV/EBITDA Average	-4.65	-3.28	-12.21	-15.88	-14.97	-8.08	-6.7	-4.87	-3.75	-16.68	-6.08	-2.38	-1.68	-2.13	-1.24
EV/EBITDA High	-9.58	-5.51	-31.06	-24.24	-21.72	-11.42	-10.68	-6.61	-5.66	-51.08	-13.8	-5.03	-4.31	-4.38	-2.04
EV/EBITDA Low	-1.51	-2.19	-3.59	-10.92	-9.8	-4.24	-4.26	-3.71	-2.59	-2.84	-3.53	-1.28	-0.8	-0.08	-0.65
EV/EBIT Average	-4.23	-3.02	-11.02	-15.25	-14.15	-7.76	-6.43	-4.61	-3.56	-16.05	-5.99	-2.34	-1.63	-2.07	-1.2
EV/EBIT High	-8.72	-5.06	-28.03	-23.28	-20.54	-10.96	-10.25	-6.26	-5.38	-49.18	-13.59	-4.93	-4.2	-4.26	-1.97
EV/EBIT Low	-1.37	-2.02	-3.24	-10.48	-9.26	-4.07	-4.09	-3.51	-2.47	-2.74	-3.47	-1.25	-0.78	-0.08	-0.63
Last Price	20.64	24	139.2	110.16	80.64	83.28	49.56	48	39.6	106.2	59.88	18.72	6.12	1.83	1.74
High Price	74.88	43.2	145.44	189.6	129.96	140.28	118.32	75.6	61.32	405.48	228	63.24	23.88	14.75	2.98
Enterprise Value Average	94	74	237	602	499	599	544	434	396	1,992	1,804	625	218	233	104
Enterprise Value High	194	125	604	919	725	847	867	589	597	6,102	4,092	1,320	560	479	171
Enterprise Value Low	30	50	70	414	327	314	346	330	274	340	1,047	335	103	9	55

Shares Outstanding	3	3	4	5	6	6	8	8	8	16	18	21	23	36	69
Diluted Weighted Avg Shares	3	3	4	5	6	6	7	8	8	13	17	20	22	27	47
Basic Weighted Avg Shares	3	3	4	5	6	6	7	8	8	13	17	20	22	27	47
Revenue per Share	3.72	1.45	3.51	2.12	7.14	5.8	6.2	3.95	0.5	0.57	0.1	0.52	0.04	0.01	- -
EBITDA per Share	-7.69	-7.96	-5.06	-7.7	-5.87	-12.15	-11.91	-11.55	-12.84	-9.24	-17.04	-13.18	-5.86	-4.02	-1.79
Operating Income per Share	-8.45	-8.67	-5.61	-8.02	-6.21	-12.66	-12.42	-12.2	-13.51	-9.6	-17.31	-13.46	-6.02	-4.14	-1.85
Basic EPS, GAAP	-5.8	-6.92	-17.19	-7.33	-5.14	-12.09	-12.94	-12.57	-14.51	-12.87	-17.45	-14.07	-6.09	-3.95	-1.81
Basic EPS from Cont Ops	-5.82	-6.93	-17.21	-7.33	-5.12	-12.09	-12.94	-12.57	-14.65	-12.96	-17.45	-14.07	-6.09	-3.95	-1.81
Diluted EPS, GAAP	-5.8	-6.92	-17.19	-7.3	-5.12	-12.09	-12.92	-12.57	-14.51	-12.87	-17.45	-14.07	-6.09	-3.95	-1.81
Diluted EPS from Cont Ops	-5.82	-6.93	-17.21	-7.3	-5.11	-12.09	-12.92	-12.57	-14.65	-12.96	-17.45	-14.07	-6.09	-3.95	-1.81
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-7.51	-7.84	-4	-6.05	-2.19	-10.25	-9.28	-9.54	-11.89	-13.77	-12.4	-10.87	-5.61	-3.83	-1.89
Free Cash Flow per Basic Share	-7.57	-7.93	-4.05	-6.33	-2.68	-10.9	-10.79	-9.81	-12.01	-13.89	-12.47	-10.92	-5.62	-3.85	-1.9
Cash & Equivalents per Share	10.75	4.55	12.01	18.5	27.08	16.97	16.92	10.03	10.6	26.44	22.15	12	6.37	2.61	0.85
Book Value per Share	16.83	11.43	11.97	21.97	29.19	19.97	18.91	10.73	0.41	29.62	22.06	10.54	5.15	1.9	0.35
Tangible Book Value per Share	9.92	5.57	8.36	19.03	26.86	17.04	16.72	8.84	-1.28	28.74	21.34	9.94	5.15	1.9	0.35

Inovio Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)